Abbott Laboratories Stock (NYSE: ABT) stock price, news, charts, stock research, profile.
Open | $113.280 |
Close | $113.660 |
Volume / Avg. | 5.278M / 5.627M |
Day Range | 112.930 - 114.020 |
52 Wk Range | 89.674 - 121.640 |
Market Cap | $197.100B |
P/E Ratio | 34.810 |
Dividend Yield | 1.940% |
Exchange | NYSE |
RSI | 46 |
Short Interest | 0.91% |
Days to Cover | 2.92 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Abbott Laboratories (NYSE: ABT) through any online brokerage.
Other companies in Abbott Laboratories’s space includes: Steris (NYSE:STE), Masimo (NASDAQ:MASI), Koninklijke Philips (NYSE:PHG), Smith & Nephew (NYSE:SNN) and Becton Dickinson (NYSE:BDX).
The latest price target for Abbott Laboratories (NYSE: ABT) was reported by RBC Capital on Wednesday, February 14, 2024. The analyst firm set a price target for 128.00 expecting ABT to rise to within 12 months (a possible 12.69% upside). 23 analyst firms have reported ratings in the last year.
The stock price for Abbott Laboratories (NYSE: ABT) is $113.59 last updated March 28, 2024 at 5:34 PM EDT.
The next Abbott Laboratories (ABT) dividend date is projected to be Friday, April 12, 2024.
Abbott Laboratories’s Q1 earnings are confirmed for Wednesday, April 17, 2024.
There is no upcoming split for Abbott Laboratories.
Abbott Laboratories is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.